Back to search results

Discovery Program for Type 1 Diabetes in Teens and Young Adults

This study is looking at whether a program called the Discovery Program can help teenagers and young adults (ages 13-21) with type 1 diabetes (T1D) manage their condition better. The Discovery Program is a special approach that combines personalized mobile health messages and support from healthcare providers. Researchers want to see if this program can improve your blood sugar control, measured by HbA1c levels (a test that shows your average blood sugar over 2-3 months). They also want to understand how it affects your stress about diabetes and your ability to manage it. You would be compared to others receiving standard diabetes care to see if the Discovery Program makes a positive difference.

Study design
This is a pilot randomized controlled trial with 150 planned participants. You would be randomly assigned to either receive the Discovery Program or standard diabetes care.
What's involved
You would engage in a 3-month intervention with mobile health communications and clinician support. You would complete surveys and assessments at the beginning, and again at 3 and 6 months.
Compensation
Not stated in the trial record.
Follow-up
Your glycemic control (HbA1c) will be measured at baseline, 3 months, 6 months, and 9 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07116434

Discovery Diabetes

Recruiting
NAAges 13–21InterventionalSupportive care
Vanderbilt University Medical Center
~150 participants
Updated 2025-12-23 on ClinicalTrials.gov
What's tested:Discovery Program

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in Glycemic Control (HbA1c)
Measured over Baseline, 3 months, 6 months, and 9 months

Conditions

Type 1 Diabetes

Explore related trials

Type 1 Diabetes Mellitus

Where it's being run

1 sites across 1 states
Tennessee1

Study leadership

  • Shelagh A Mulvaney, PhD · PRINCIPAL_INVESTIGATOR · Vanderbilt University

Who to contact

Abigail Doyle, MSHI
[email protected]
615-343-6075
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Adolescents (13-17 years) and young adults (aged 18-21 years),
Diagnosed with T1D for at least one year,
Access to a smartphone,
A My Health at Vanderbilt (MHAV) patient portal account,
Ability to read, speak, and understand English,
An appointment with an NP in the VUMC Eskind Clinic within 7 months of initial contact

Exclusion

Diagnosis of type 2 diabetes
Any physical, cognitive, sensory or emotional condition precluding participation in the intervention (seeing/using a phone, hearing digital stories, answering questions).

What this trial measures

  • Change in Glycemic Control (HbA1c)Baseline, 3 months, 6 months, and 9 months

    This outcome measure will assess the change in glycemic control among participants, as indicated by changes in HbA1c levels. The primary aim is to determine whether the Discovery Program leads to significant improvements in glycemic control compared to standard diabetes care.